Irritable Bowel Syndrome I: Introduction

Irritable bowel syndrome is a functional disorder affecting the GI tract that causes symptoms without structural or biochemical abnormalities. Unlike inflammatory bowel disease, IBS involves no visible tissue damage or inflammation. It primarily affects the large intestine and presents as a chronic condition characterized by abdominal pain, bloating, gas, diarrhea, constipation, or alternating patterns of both.

Altered gut motility involves abnormal muscle contractions in the gastrointestinal tract that disrupt coordinated food movement. Increased motility accelerates transit time, leading to diarrhea, while decreased motility slows movement, causing constipation. The enteric nervous system, which regulates gut motility, may dysfunction in IBS, exacerbating irregular muscle contractions and symptom severity.

Visceral hypersensitivity occurs when sensory receptors in the gut wall become unusually sensitive to normal digestive signals. Irritated or overactive gut areas send pain signals through nerves to the spinal cord and brain, causing abdominal pain and discomfort. Chronic activation of these nociceptive pathways can lead to central sensitization, where the brain becomes increasingly responsive to visceral stimuli, amplifying pain perception.

Neurotransmitter imbalances, particularly serotonin dysregulation, disrupt bidirectional gut-brain axis communication. Serotonin, crucial for regulating bowel function, influences both gastrointestinal and mood regulation. Other neurotransmitters like gamma-aminobutyric acid and dopamine also regulate nervous system-gut interactions. These imbalances can trigger or worsen IBS symptoms through impaired signaling between the brain and digestive system.

Dysbiosis is an imbalance in gut microbiota composition and diversity that affects gut health and function. Changes in microbial populations can impair food processing, increase gas production, and trigger inflammation. Altered microbial metabolites, such as short-chain fatty acids, may disrupt gut motility and immune responses. These microbial changes collectively exacerbate IBS symptoms in susceptible individuals.

Multiple factors trigger IBS symptoms, including food intolerance to specific carbohydrates and FODMAPs, which influence gut fermentation and gas production. Stress and emotional factors impact the gut-brain axis bidirectionally, exacerbating symptoms, while gastrointestinal symptoms can induce stress, creating a feedback loop. Genetic predisposition also influences individual susceptibility to developing IBS.

Low-grade inflammation within the intestines can contribute to IBS symptom manifestation. Various factors, including prior infections or immune system dysregulation, may trigger this inflammation. Additionally, stress and emotional factors can amplify inflammatory responses through the gut-brain axis. Understanding these inflammatory mechanisms helps explain why medical and nursing management strategies target symptom relief and inflammation reduction.